OncoMatch/Clinical Trials/NCT06940947

Endoscopic Therapy Or Surgery for Early Colon Cancer

Is NCT06940947 recruiting? Yes, currently enrolling (May 2026). This Phase 3 trial studies non-drug interventions for colon cancer.

Phase 3RecruitingNorwegian Department of Health and Social AffairsNCT06940947Data as of May 2026

The trial is a randomized head-to-head comparison of the benefits, harms and burdens of endoscopic full-thickness resection (eFTR), a novel, minimally invasive endoscopic treatment modality, for early colon cancer as compared to standard-of-care surgery.

Check if I qualify

Extracted eligibility criteria

Cancer type

Colorectal Cancer

Prior therapy

No prior treatment (treatment-naive required)

Structured fields extracted by AI. May contain errors — verify against the official protocol.

Could you qualify for this trial?

Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.

Check if I qualify